Methylprednisolone Dosing for Brain-Dead Organ Donors
For brain-dead organ donors, administer methylprednisolone 15 mg/kg as a single bolus dose as part of hormonal resuscitation protocols. This is the established standard based on consensus guidelines for maximizing organ recovery 1.
Recommended Dosing Protocol
The 2002 Bethesda Consensus Conference on cardiac donor management specifically recommends:
- Methylprednisolone: 15 mg/kg bolus 1
- Administered as part of hormonal resuscitation when left ventricular ejection fraction is <45%
- Given alongside triiodothyronine (T3) and arginine vasopressin
This protocol has been incorporated into the UNOS critical pathway for donor management 1.
Clinical Context and Timing
Administer methylprednisolone early in the donor management process, ideally:
- After brain death declaration and initial hemodynamic stabilization
- When aggressive donor management is initiated
- Before significant hemodynamic deterioration occurs
The rationale is to suppress the cytokine cascade and inflammatory response triggered by brain death, which damages organs and reduces transplant success 2, 3.
Supporting Evidence
Multiple studies support this dosing:
- Research demonstrates that 15 mg/kg methylprednisolone significantly reduces inflammatory cytokines (IL-2, IL-6, TNF-α), improves hemodynamic stability, and enhances organ quality 4, 2
- One study using 1 gram total dose (given as 500 mg × 2) showed improved hemodynamic parameters in unstable donors 5, though this represents a lower dose for most adult patients
- Lower-dose protocols (300 mg hydrocortisone equivalent) have been studied but the 15 mg/kg methylprednisolone remains the guideline-recommended standard 6
Important Caveats
Monitor for hyperglycemia: High-dose steroids can worsen glucose control. Maintain blood glucose 120-180 mg/dL with insulin infusion (minimum 1 U/h, titrated as needed) 1.
Administration considerations:
- For a 70 kg patient, this equals approximately 1,050 mg (roughly 1 gram)
- Can be given as IV bolus over several minutes or diluted in normal saline 7
- The FDA label notes cardiac arrhythmias with doses >0.5 grams given over <10 minutes, so infuse over at least 10-30 minutes for safety 7
The older 1993 guidelines 8 did not routinely recommend thyroid hormone supplementation, but the more recent 2002 consensus 1 includes it as part of comprehensive hormonal resuscitation—prioritize the 2002 protocol as it represents current standard practice.